Unleashing Cellular Power Plants: How They Control Inflammation and Impact Health

Researchers at the University of Freiburg found that mitochondria, the cell’s power plants, impact whether cells live or die under stress. When energy production stops suddenly, cells do not undergo apoptosis, or programmed cell death. Instead, they trigger an inflammatory response. This discovery was published in the journal Immunity on November 20, 2024.

Prof. Dr. Olaf Groß, the study’s lead researcher, stated that mitochondria help cells decide between silent apoptosis and a response that releases inflammatory signals. This finding enhances our understanding of how the body balances cell protection and defense, potentially opening new treatments for inflammatory diseases.

Cells use ATP (adenosine triphosphate) as their fuel. A drop in ATP keeps cytochrome c, a key protein for apoptosis, trapped in the mitochondria, preventing cell death. Instead, mitochondria prompt the release of inflammatory signals, making tissues alert to threats.

The study identified NLRP3, a sensor that activates when mitochondria stop producing energy. This sensor requires a second signal from other areas of the cell to initiate inflammation. This two-signal mechanism prevents unnecessary inflammation and protects healthy cells, allowing the body to respond appropriately to serious threats.

This research may lead to new treatments for conditions involving inflammation, such as gout, type 2 diabetes, and acute COVID-19 cases. Future drugs could target mitochondria or NLRP3 activation to control inflammation. This strategy aims to protect healthy tissue while enhancing immune responses to infections and cancer.